ES2129397T3 - Derivados heteroaroilo de antibioticos beta-lactamas monociclicos. - Google Patents

Derivados heteroaroilo de antibioticos beta-lactamas monociclicos.

Info

Publication number
ES2129397T3
ES2129397T3 ES91118838T ES91118838T ES2129397T3 ES 2129397 T3 ES2129397 T3 ES 2129397T3 ES 91118838 T ES91118838 T ES 91118838T ES 91118838 T ES91118838 T ES 91118838T ES 2129397 T3 ES2129397 T3 ES 2129397T3
Authority
ES
Spain
Prior art keywords
heteroaroil
derivatives
lactam antibiotics
monocycle beta
monocycle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91118838T
Other languages
English (en)
Inventor
William H Koster
Joseph E Sundeen
Henner Straub
Peter Hans Ermann
Uwe D Treuner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Application granted granted Critical
Publication of ES2129397T3 publication Critical patent/ES2129397T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40—Benzopyrazines
    • C07D241/42—Benzopyrazines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/50—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms
    • C07D241/52—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/78—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C217/80—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings
    • C07C217/82—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring
    • C07C217/84—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring the oxygen atom of at least one of the etherified hydroxy groups being further bound to an acyclic carbon atom
    • C07C217/86—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring the oxygen atom of at least one of the etherified hydroxy groups being further bound to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/62—Compounds containing any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylcarbamates
    • C07C271/66—Y being a hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40—Benzopyrazines
    • C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
    • C07F9/650994—Six-membered rings having the nitrogen atoms in the positions 1 and 4 condensed with carbocyclic rings or carbocyclic ring systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Luminescent Compositions (AREA)

Abstract

NUEVOS COMPUESTOS QUE EXHIBEN ACTIVIDAD ANTIBACTERIANA Y TIENEN LA FORMULA .
ES91118838T 1990-11-05 1991-11-05 Derivados heteroaroilo de antibioticos beta-lactamas monociclicos. Expired - Lifetime ES2129397T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60894590A 1990-11-05 1990-11-05

Publications (1)

Publication Number Publication Date
ES2129397T3 true ES2129397T3 (es) 1999-06-16

Family

ID=24438745

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91118838T Expired - Lifetime ES2129397T3 (es) 1990-11-05 1991-11-05 Derivados heteroaroilo de antibioticos beta-lactamas monociclicos.

Country Status (27)

Country Link
US (3) US5290929A (es)
EP (1) EP0484881B1 (es)
JP (2) JP3157565B2 (es)
KR (4) KR100210631B1 (es)
CN (3) CN1159303C (es)
AT (1) ATE178604T1 (es)
AU (2) AU648835B2 (es)
CA (1) CA2053359C (es)
CZ (1) CZ289671B6 (es)
DE (1) DE69131090T2 (es)
DK (1) DK0484881T3 (es)
ES (1) ES2129397T3 (es)
FI (1) FI915194A (es)
GR (1) GR3030572T3 (es)
HU (1) HU211402B (es)
IE (1) IE913565A1 (es)
IL (3) IL99829A (es)
MX (1) MX9101767A (es)
MY (2) MY113385A (es)
NO (1) NO914320L (es)
NZ (5) NZ240382A (es)
PL (1) PL167312B1 (es)
PT (1) PT99427A (es)
SK (1) SK282124B6 (es)
UY (1) UY23318A1 (es)
YU (1) YU175791A (es)
ZA (1) ZA918014B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5232918A (en) * 1987-07-23 1993-08-03 Imperial Chemical Industries Plc Cephalosporin derivatives
ZA918014B (en) * 1990-11-05 1992-07-29 Squibb & Sons Inc Heteroaroyl derivatives of monocyclic beta-lactam antibiotics
US5250691A (en) * 1991-09-09 1993-10-05 E. R. Squibb & Sons, Inc. Heteroaryl derivatives of monocyclic beta-lactam antibiotics
US5888998A (en) * 1997-04-24 1999-03-30 Synphar Laboratories, Inc. 2-oxo-1-azetidine sulfonic acid derivatives as potent β-lactamase inhibitors
US5994340A (en) * 1997-08-29 1999-11-30 Synphar Laboratories, Inc. Azetidinone derivatives as β-lactamase inhibitors
DK1223915T3 (da) * 1999-10-29 2006-03-06 Nektar Therapeutics Törpulverpræparater med forbedret dispersivitet
US20030133925A1 (en) * 2001-09-28 2003-07-17 Shawar Ribhi M. Monobactam compositions and methods of use thereof
CA2629570C (en) * 2005-12-07 2012-11-27 Basilea Pharmaceutica Ag Useful combinations of monobactam antibiotics with beta-lactamase inhibitors
UY34585A (es) 2012-01-24 2013-09-02 Aicuris Gmbh & Co Kg Compuestos b-lactámicos sustituidos con amidina, su preparación y uso
CN103896964B (zh) * 2014-03-31 2016-04-13 南京工业大学 一类头孢中间体的制备方法
KR101583937B1 (ko) * 2014-06-09 2016-01-08 현대자동차주식회사 자동차용 연료센더 장치
CN105017167B (zh) * 2015-07-20 2017-10-20 新乡医学院 一种喹喔啉类化合物的制备方法
MA47110A (fr) 2016-12-21 2019-10-30 Aicuris Gmbh & Co Kg Polythérapie avec des composés de ss-lactame substitués par amidine et des inhibiteurs de ss-lactamase pour des infections par des souches bactériennes résistantes aux antibiotiques
WO2019144969A1 (zh) 2018-01-29 2019-08-01 南京明德新药研发股份有限公司 用于治疗细菌感染的单环β-内酰胺化合物
EP4079305A4 (en) 2019-12-19 2024-01-10 Shenzhen Optimum Biological Technology Co., Ltd APPLICATION OF A COMPOUND IN THE PREPARATION OF DRUG
US11932637B2 (en) * 2021-11-18 2024-03-19 Merck Sharp & Dohme Llc Chromane amidine monobactam compounds for the treatment of bacterial infections

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1408675A (en) * 1973-03-16 1975-10-01 Allen & Hanburys Ltd Amides derived from quinoxaline
US4217453A (en) * 1978-07-24 1980-08-12 Merck & Co., Inc. 6-Amido-3-substituted-amino-1-azabicyclo[3.2.0]hept-2-en-7-one-2-carboxylic acid
PH15791A (en) * 1978-10-20 1983-03-25 Lilly Co Eli Pharmaceutical composition containing 3,4-dihydro-3-oxoquinoxalines
US4224336A (en) * 1979-04-17 1980-09-23 Merck & Co., Inc. 3-(2-Aminoethylthio)-6-amido-7-oxo-1-azabicyclo[3.2.0]-hept-2-ene-2-carboxylic acid
US4775670A (en) * 1980-09-29 1988-10-04 E. R. Squibb & Sons, Inc. 2-oxo-1-azetidinesulfonic acid salts
US4587047A (en) * 1981-04-09 1986-05-06 E. R. Squibb & Sons, Inc. 2-oxo-1-[[(substituted sulfonyl)amino]-carbonyl]azetidines
US4670553A (en) * 1982-01-04 1987-06-02 E. R. Squibb & Sons, Inc. 2-oxo-1-(aminocarbonylaminosulfonyl-aminocarbonyl)azetidines
US4566876A (en) * 1983-03-10 1986-01-28 Clairol Incorporated Meta-phenylenediamine coupler compounds and oxidative hair dye compositions and methods using same
US4610824A (en) * 1984-10-09 1986-09-09 E. R. Squibb & Sons, Inc. Hydrazide derivatives of monocyclic beta-lactam antibiotics
US4743685A (en) * 1985-09-26 1988-05-10 E. R. Squibb & Sons, Inc. 2-oxo-1-[[(substituted sulfonyl)amino]carbonyl]azetidines
FI872879A (fi) * 1986-07-21 1988-01-22 Sankei Yakuhin Kk --laktamfoerening, foerfarande foer dess framstaellning, denna innehaollande laekemedelskomposition foer behandling av sjukdom med bakterieinfektion samt mellanprodukter foer dess syntes.
US4772693A (en) * 1987-07-01 1988-09-20 E. R. Squibb & Sons, Inc. 2-oxo-1-((Substituted sulfonyl)amino)-carbonyl)azetidines
GB8816519D0 (en) * 1987-07-23 1988-08-17 Ici Plc Antibiotic compounds
US4904775A (en) * 1988-05-16 1990-02-27 E. R. Squibb & Sons, Inc. Heteroaroylhydrazide derivatives of monocyclic beta-lactam antibiotics
US5037983A (en) * 1988-05-16 1991-08-06 E. R. Squibb & Sons, Inc. 6,7-dihydroxyquinoxalines as intermediates to beta-lactam antibiotics
US4959470A (en) * 1988-08-17 1990-09-25 E. R. Squibb & Sons, Inc. 2-oxo-[[(substituted sulfonyl)-amino]carbonyl]-azetidines
CA2024282A1 (en) * 1989-09-21 1991-03-22 Peter H. Ermann Heterocyclic hydrazide derivatives of monocyclic beta-lactam antibiotics
US5030724A (en) * 1990-01-22 1991-07-09 E. R. Squibb & Sons, Inc. Monobactam hydrazides containing catechol sulfonic acid groups
ZA918014B (en) * 1990-11-05 1992-07-29 Squibb & Sons Inc Heteroaroyl derivatives of monocyclic beta-lactam antibiotics
US5250691A (en) * 1991-09-09 1993-10-05 E. R. Squibb & Sons, Inc. Heteroaryl derivatives of monocyclic beta-lactam antibiotics

Also Published As

Publication number Publication date
NO914320L (no) 1992-05-06
EP0484881B1 (en) 1999-04-07
MX9101767A (es) 1992-07-08
DK0484881T3 (da) 1999-10-18
CS334591A3 (en) 1992-05-13
CN1031825C (zh) 1996-05-22
IL118368A0 (en) 1996-09-12
KR100228469B1 (ko) 2000-03-15
CN1113228A (zh) 1995-12-13
UY23318A1 (es) 1992-04-24
AU6889294A (en) 1994-10-06
DE69131090T2 (de) 1999-09-23
IL118367A0 (en) 1996-09-12
MY107454A (en) 1995-12-30
IL99829A0 (en) 1992-08-18
JP3157565B2 (ja) 2001-04-16
AU648835B2 (en) 1994-05-05
AU659780B2 (en) 1995-05-25
CN1067053C (zh) 2001-06-13
CN1251836A (zh) 2000-05-03
PL167312B1 (pl) 1995-08-31
CN1061414A (zh) 1992-05-27
MY113385A (en) 2002-02-28
HU913462D0 (en) 1992-01-28
JP2000239246A (ja) 2000-09-05
JP3299734B2 (ja) 2002-07-08
CZ289671B6 (cs) 2002-03-13
PL292287A1 (en) 1992-06-01
CN1159303C (zh) 2004-07-28
US5290929A (en) 1994-03-01
KR100221505B1 (ko) 2000-03-15
IL99829A (en) 1997-01-10
HUT59921A (en) 1992-07-28
IE913565A1 (en) 1992-05-22
NZ280077A (en) 1997-01-29
GR3030572T3 (en) 1999-10-29
NZ260513A (en) 1997-01-29
NZ272437A (en) 1997-01-29
EP0484881A3 (en) 1992-10-14
JPH04283579A (ja) 1992-10-08
NO914320D0 (no) 1991-11-04
SK282124B6 (sk) 2001-11-06
KR100248590B1 (en) 2000-03-15
KR100210631B1 (ko) 1999-07-15
HU211402B (en) 1995-11-28
ATE178604T1 (de) 1999-04-15
IL118368A (en) 1997-09-30
KR920009827A (ko) 1992-06-25
FI915194A (fi) 1992-05-06
NZ240382A (en) 1997-01-29
EP0484881A2 (en) 1992-05-13
PT99427A (pt) 1992-09-30
CA2053359C (en) 2004-01-13
YU175791A (sh) 1994-01-20
NZ272438A (en) 1997-01-29
FI915194A0 (fi) 1991-11-04
AU8694191A (en) 1992-05-07
US5420277A (en) 1995-05-30
CA2053359A1 (en) 1992-05-06
DE69131090D1 (de) 1999-05-12
ZA918014B (en) 1992-07-29
US5705645A (en) 1998-01-06

Similar Documents

Publication Publication Date Title
FI914928A0 (fi) Hydroximetyl (metylencyklopentyl) puriner och -pyrimidiner.
FI932944A0 (fi) Amider av antibiot GE 2270 faktorer
ES2129397T3 (es) Derivados heteroaroilo de antibioticos beta-lactamas monociclicos.
ES2088537T3 (es) Derivados de piranil cianoguanidina.
AU7194991A (en) Macrolide pharmaceutical solutions
SE9100920D0 (sv) New active compounds
ATE141272T1 (de) Beta-lactam-verbindungen und ihre herstellung
ES2106058T3 (es) Derivados de benzamida.
KR950704333A (ko) 신규한 세펨 유도체(novel cephem derivatives)
FI933755A0 (fi) Foerfarande foer framstaellning av trans-piperidin-2,5-dikarboxylater
ES2093051T3 (es) Purinil- y pirimidil-tetrahidrofuranos.
ATE127806T1 (de) Antibiotikverbindungen und ihre herstellung.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 484881

Country of ref document: ES